Table 1.

Comparison of total hematopoietic progenitors emerging from muscle and neural tissue to changes in total number of specific phenotypically characterized subsets

De novo10% CEEHGFHGF + BMP-4 + EPO
Muscle tissue     
 Total cells 500 000 920 000 330 000 320 000 
 AC133+ 190 000 11 612 28 139 
 CD34+ 23 500 87 400 46 054 41 195 
 CD45+ 1 025 5 165 
 CD34+CD45+   600 59 
 Total hematopoietic progenitors 8  182 630 
Neural tissue     
 Total cells 500 000 120 000 110 000 82 000 
 AC133+ 97 450 291 1 116 658 
 CD34+ 21 650 1 087 283 789 
 CD45+ 4 850 2 388 9 843 9 574 
 CD34+CD45+ 95  669 541 132 
 Total hematopoietic progenitors 1  507 2 475 
De novo10% CEEHGFHGF + BMP-4 + EPO
Muscle tissue     
 Total cells 500 000 920 000 330 000 320 000 
 AC133+ 190 000 11 612 28 139 
 CD34+ 23 500 87 400 46 054 41 195 
 CD45+ 1 025 5 165 
 CD34+CD45+   600 59 
 Total hematopoietic progenitors 8  182 630 
Neural tissue     
 Total cells 500 000 120 000 110 000 82 000 
 AC133+ 97 450 291 1 116 658 
 CD34+ 21 650 1 087 283 789 
 CD45+ 4 850 2 388 9 843 9 574 
 CD34+CD45+ 95  669 541 132 
 Total hematopoietic progenitors 1  507 2 475 

Flow cytometry was used to assess the expression of human-specific cell surface proteins AC133, CD34, CD45, and double-positive CD34/CD45 before and after in vitro culture in serum-free media containing either 10% chicken embryonic extract (CEE) or human hematopoietic growth factors (HGFs) alone or with bone morphogenetic protein-4 (BMP-4) and erythropoietin (EPO) for a total of 500 000 human muscle– and human neural–derived cells. Values show average absolute number of cells of each phenotype. Absolute number of detected hematopoietic progenitors after culture in each medium is given. Treated human muscle and neural cells maintained normal expression of tissue-specific markers (myosin for muscle and nestin for neural tissue) irrespective of changes in hematopoietic cell surface phenotype as shown in Figure 3.

Close Modal

or Create an Account

Close Modal
Close Modal